Megan C Prunty1, Moe H Aung1, Adam M Hanif2, Rachael S Allen2, Micah A Chrenek1, Jeffrey H Boatright3, Peter M Thule4, Kousik Kundu5, Niren Murthy6, Machelle T Pardue3. 1. Department of Ophthalmology, Emory University, Atlanta, Georgia, United States. 2. Atlanta VA Center for Visual and Neurocognitive Rehabilitation, Atlanta, Georgia, United States. 3. Department of Ophthalmology, Emory University, Atlanta, Georgia, United States 2Atlanta VA Center for Visual and Neurocognitive Rehabilitation, Atlanta, Georgia, United States. 4. Biomedical Research, Atlanta VA Medical Center, Atlanta, Georgia, United States 4Department of Medicine, Emory University, Atlanta, Georgia, United States. 5. LI-COR, Lincoln, Nebraska, United States. 6. Department of Bioengineering, University of California, Berkeley, California, United States.
Abstract
PURPOSE: In vivo methods for detecting oxidative stress in the eye would improve screening and monitoring of the leading causes of blindness: diabetic retinopathy, glaucoma, and age-related macular degeneration. METHODS: To develop an in vivo biomarker for oxidative stress in the eye, we tested the efficacy of a reactive oxygen species (ROS)-activated, near-infrared hydrocyanine-800CW (H-800CW) fluorescent probe in light-induced retinal degeneration (LIRD) mouse models. After intravitreal delivery in LIRD rats, fluorescent microscopy was used to confirm that the oxidized H-800CW appeared in the same retinal layers as an established ROS marker (dichlorofluorescein). RESULTS: Dose-response curves of increasing concentrations of intravenously injected H-800CW demonstrated linear increases in both intensity and total area of fundus hyperfluorescence in LIRD mice, as detected by scanning laser ophthalmoscopy. Fundus hyperfluorescence also correlated with the duration of light damage and functional deficits in vision after LIRD. In LIRD rats with intravitreal injections of H-800CW, fluorescent labeling was localized to photoreceptor inner segments, similar to dichlorofluorescein. CONCLUSIONS: Hydrocyanine-800CW detects retinal ROS in vivo and shows potential as a novel biomarker for ROS levels in ophthalmic diseases.
PURPOSE: In vivo methods for detecting oxidative stress in the eye would improve screening and monitoring of the leading causes of blindness: diabetic retinopathy, glaucoma, and age-related macular degeneration. METHODS: To develop an in vivo biomarker for oxidative stress in the eye, we tested the efficacy of a reactive oxygen species (ROS)-activated, near-infrared hydrocyanine-800CW (H-800CW) fluorescent probe in light-induced retinal degeneration (LIRD) mouse models. After intravitreal delivery in LIRD rats, fluorescent microscopy was used to confirm that the oxidized H-800CW appeared in the same retinal layers as an established ROS marker (dichlorofluorescein). RESULTS: Dose-response curves of increasing concentrations of intravenously injected H-800CW demonstrated linear increases in both intensity and total area of fundus hyperfluorescence in LIRD mice, as detected by scanning laser ophthalmoscopy. Fundus hyperfluorescence also correlated with the duration of light damage and functional deficits in vision after LIRD. In LIRD rats with intravitreal injections of H-800CW, fluorescent labeling was localized to photoreceptor inner segments, similar to dichlorofluorescein. CONCLUSIONS:Hydrocyanine-800CW detects retinal ROS in vivo and shows potential as a novel biomarker for ROS levels in ophthalmic diseases.
Authors: Sung Wook Park; Chang Sik Cho; Hyoung Oh Jun; Nam Hee Ryu; Jin Hyoung Kim; Young Suk Yu; Jin Sook Kim; Jeong Hun Kim Journal: Invest Ophthalmol Vis Sci Date: 2012-11-19 Impact factor: 4.799
Authors: Moe H Aung; Moon K Kim; Darin E Olson; Peter M Thule; Machelle T Pardue Journal: Invest Ophthalmol Vis Sci Date: 2013-02-15 Impact factor: 4.799
Authors: Selena Magalotti; Tiffany P Gustafson; Qian Cao; Dana R Abendschein; Richard A Pierce; Mikhail Y Berezin; Walter J Akers Journal: Mol Imaging Biol Date: 2013-08 Impact factor: 3.488
Authors: Bruce A Berkowitz; Jacob Lenning; Nikita Khetarpal; Catherine Tran; Johnny Y Wu; Ali M Berri; Kristin Dernay; E Mark Haacke; Fatema Shafie-Khorassani; Robert H Podolsky; John C Gant; Shaniya Maimaiti; Olivier Thibault; Geoffrey G Murphy; Brian M Bennett; Robin Roberts Journal: FASEB J Date: 2017-06-07 Impact factor: 5.191
Authors: Xiqian Jiang; Lingfei Wang; Shaina L Carroll; Jianwei Chen; Meng C Wang; Jin Wang Journal: Antioxid Redox Signal Date: 2018-02-16 Impact factor: 8.401
Authors: Marie Billaud; Julie A Phillippi; Mary P Kotlarczyk; Jennifer C Hill; Bradley W Ellis; Claudette M St Croix; Nadiezhda Cantu-Medéllin; Eric E Kelley; Thomas G Gleason Journal: J Thorac Cardiovasc Surg Date: 2017-05-25 Impact factor: 5.209
Authors: Ning Fan; Sean M Silverman; Yang Liu; Xizhen Wang; Byung-Jin Kim; Liping Tang; Abbot F Clark; Xuyang Liu; Iok-Hou Pang Journal: Exp Eye Res Date: 2017-06-08 Impact factor: 3.467
Authors: Bruce A Berkowitz; Bryce X Bredell; Christopher Davis; Marijana Samardzija; Christian Grimm; Robin Roberts Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799
Authors: Bruce A Berkowitz; Alfred S Lewin; Manas R Biswal; Bryce X Bredell; Christopher Davis; Robin Roberts Journal: Invest Ophthalmol Vis Sci Date: 2016-02 Impact factor: 4.799